
    
      Eligible study patients diagnosed with POAG and not sufficiently controlled by, intolerant
      of, or non-compliant with their current IOP-lowering regimen. Patients with IOP>21 mm Hg upon
      at least two consecutive measurements. Study subjects with typical glaucomatous visual field
      (VF) loss on Octopus or Humphrey automated perimetry (Carl Zeiss Meditec, Dublin, CA) and
      glaucomatous alterations to the optic nerve head. Visual field classified as glaucomatous
      according to the European Glaucoma Society guidelines.

      Exclusion criteria : eye surgery in the previous 6 months, any previous surgery for glaucoma,
      evidence of glaucoma of a type other than POAG, and medication with systemic or topical
      steroids.
    
  